Skip to main content
Top
Published in: Abdominal Radiology 6/2022

01-06-2022 | Kidney Cancer | Interventional Radiology

Split-bolus CT urography after microwave ablation of renal cell carcinoma improves image quality and reduces radiation exposure

Authors: Alex P. Tannenbaum, Meghan G. Lubner, Ayman Mithqal, Timothy J. Ziemlewicz, Glenn O. Allen, Christopher L. Brace, E. Jason Abel, Lori Mankowski-Gettle, Noah S. Schenkman, Shane A. Wells

Published in: Abdominal Radiology | Issue 6/2022

Login to get access

Abstract

Objective

To compare image quality and radiation dose between single-bolus 2-phase and split-bolus 1-phase CT Urography (CTU) performed immediately after microwave ablation (MWA) of clinically localized T1 (cT1) RCC.

Methods

Forty-two consecutive patients (30 M, mean age 67.5 ± 9.0) with cT1 RCC were treated with MWA from 7/2013 to 12/2013 at two academic quaternary-care institutions. Renal parenchymal enhancement, collecting system opacification and distention and size-specific dose estimate (SSDE) were quantified and image quality subjectively assessed on single-bolus 2-phase versus split-bolus 1-phase CTU. Kruskal–Wallis and Pearson’s Chi-squared tests were performed to assess differences in continuous and categorical variables, respectively. Two-sample T test with equal variances was used to determine differences in quantitative and qualitative image data.

Results

Median tumor diameter was larger [2.9 cm (IQR 1.7–5.3) vs 3.6 cm (IQR 1.7–5.7), p = 0.01] in the split-bolus cohort. Mean abdominal girth (p = 0.20) was similar. Number of antennas used and unenhanced CTs obtained before and during MWA were similar (p = 0.11–0.32). Renal pelvis opacification (2.5 vs 3.5, p < 0.001) and distention (4 mm vs 8 mm, p < 0.001) were improved and renal enhancement (Right: 127 HU vs 177 HU, p = 0.001; Left: 124 HU vs 185 HU, p < 0.001) was higher for the split-bolus CTU. Image quality was superior for split-bolus CTU (3.2 vs 4.0, p = 0.004). Mean SSDE for the split-bolus CTU was significantly lower [163.9 mGy (SD ± 73.9) vs 36.3 mGy (SD ± 7.7), p < 0.001].

Conclusion

Split-bolus CTU immediately after MWA of cT1 RCC offers higher image quality, improved opacification/distention of the collecting system and renal parenchymal enhancement at a lower radiation dose.
Literature
1.
go back to reference Capitanio U, Bensalah K, Bex A, et al (2019) Epidemiology of renal cell carcinoma. Eur Urol 75 (1):74-84.CrossRef Capitanio U, Bensalah K, Bex A, et al (2019) Epidemiology of renal cell carcinoma. Eur Urol 75 (1):74-84.CrossRef
2.
go back to reference Wells SA, Wong VK, Wittmann TA, et al (2017) Renal mass biopsy and thermal ablation: Should biopsy be performed before or during the ablation procedure? Abdom Radiol (NY) 42 (6):1773-1780.CrossRef Wells SA, Wong VK, Wittmann TA, et al (2017) Renal mass biopsy and thermal ablation: Should biopsy be performed before or during the ablation procedure? Abdom Radiol (NY) 42 (6):1773-1780.CrossRef
3.
go back to reference Posielski NM, Bui A, Wells SA, et al (2019) Risk factors for complications and nondiagnostic results following 1,155 consecutive percutaneous core renal mass biopsies. J Urol 201 (6):1080-1087.CrossRef Posielski NM, Bui A, Wells SA, et al (2019) Risk factors for complications and nondiagnostic results following 1,155 consecutive percutaneous core renal mass biopsies. J Urol 201 (6):1080-1087.CrossRef
4.
go back to reference Maciolek KA, Abel EJ, Posielski NM, et al (2019) Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma. Eur Radiol 29 (11):6319-6329.CrossRef Maciolek KA, Abel EJ, Posielski NM, et al (2019) Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma. Eur Radiol 29 (11):6319-6329.CrossRef
5.
go back to reference Campbell S, Uzzo RG, Allaf ME, et al (2017) Renal mass and localized renal cancer: AUA Guideline. J Urol 198 (3):520-529.CrossRef Campbell S, Uzzo RG, Allaf ME, et al (2017) Renal mass and localized renal cancer: AUA Guideline. J Urol 198 (3):520-529.CrossRef
6.
go back to reference Pierorazio PM, Johnson MH, Patel HD, et al (2016) Management of renal masses and localized renal cancer: Systematic review and meta-analysis. J Urol 196 (4):989-999.CrossRef Pierorazio PM, Johnson MH, Patel HD, et al (2016) Management of renal masses and localized renal cancer: Systematic review and meta-analysis. J Urol 196 (4):989-999.CrossRef
7.
go back to reference Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA (2013) Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 63 (3):486-492.CrossRef Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA (2013) Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 63 (3):486-492.CrossRef
8.
go back to reference Andrews JR, Atwell T, Schmit G, et al (2019) Oncologic outcomes following partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 76 (2):244-251.CrossRef Andrews JR, Atwell T, Schmit G, et al (2019) Oncologic outcomes following partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 76 (2):244-251.CrossRef
9.
go back to reference Breen DJ, King AJ, Patel N, Lockyer R, Hayes M (2018) Image-guided cryoablation for sporadic renal cell carcinoma: Three- and 5-year outcomes in 220 patients with biopsy-proven renal cell carcinoma. Radiology 289 (2):554-561.CrossRef Breen DJ, King AJ, Patel N, Lockyer R, Hayes M (2018) Image-guided cryoablation for sporadic renal cell carcinoma: Three- and 5-year outcomes in 220 patients with biopsy-proven renal cell carcinoma. Radiology 289 (2):554-561.CrossRef
10.
go back to reference Yu J, Zhang X, Liu H, et al (2020) Percutaneous microwave ablation versus laparoscopic partial nephrectomy for cT1a renal cell carcinoma: A propensity-matched cohort study of 1955 patients. Radiology 294 (3):698-706.CrossRef Yu J, Zhang X, Liu H, et al (2020) Percutaneous microwave ablation versus laparoscopic partial nephrectomy for cT1a renal cell carcinoma: A propensity-matched cohort study of 1955 patients. Radiology 294 (3):698-706.CrossRef
11.
go back to reference Brace C (2011) Thermal tumor ablation in clinical use. IEEE Pulse 2 (5):28-38.CrossRef Brace C (2011) Thermal tumor ablation in clinical use. IEEE Pulse 2 (5):28-38.CrossRef
12.
go back to reference McClure TD, Chow DS, Tan N, Sayre JA, Pantuck AJ, Raman SS (2014) Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas. J Vasc Interv Radiol 25 (11):1682-1688.CrossRef McClure TD, Chow DS, Tan N, Sayre JA, Pantuck AJ, Raman SS (2014) Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas. J Vasc Interv Radiol 25 (11):1682-1688.CrossRef
13.
go back to reference Curci NE, Triche BL, Abel EJ, et al (2021) Effect of iodinated contrast material on post-operative eGFR when administered during renal mass ablation. Eur Radiol 31 (8):5490-5497.CrossRef Curci NE, Triche BL, Abel EJ, et al (2021) Effect of iodinated contrast material on post-operative eGFR when administered during renal mass ablation. Eur Radiol 31 (8):5490-5497.CrossRef
14.
go back to reference Dillman JR, Caoili EM, Cohan RH, et al (2007) Comparison of urinary tract distention and opacification using single-bolus 3-phase vs split-bolus 2-phase multidetector row CT urography. J Comput Assist Tomogr 31:750-757.CrossRef Dillman JR, Caoili EM, Cohan RH, et al (2007) Comparison of urinary tract distention and opacification using single-bolus 3-phase vs split-bolus 2-phase multidetector row CT urography. J Comput Assist Tomogr 31:750-757.CrossRef
15.
go back to reference Wang LJ, Wong YC, Chuang CK, Huang CC, Pang ST (2009) Diagnostic accuracy of transitional cell carcinoma on multidetector computerized tomography urography in patients with gross hematuria. J Urol 181 (2):524-531.CrossRef Wang LJ, Wong YC, Chuang CK, Huang CC, Pang ST (2009) Diagnostic accuracy of transitional cell carcinoma on multidetector computerized tomography urography in patients with gross hematuria. J Urol 181 (2):524-531.CrossRef
16.
go back to reference Page L, Wei W, Kundra V, Rong XJ (2016) Dose reduction in CT urography and vasculature phantom studies using model-based iterative reconstruction. J Appl Clin Med Phys 17 (6):334-342.CrossRef Page L, Wei W, Kundra V, Rong XJ (2016) Dose reduction in CT urography and vasculature phantom studies using model-based iterative reconstruction. J Appl Clin Med Phys 17 (6):334-342.CrossRef
17.
go back to reference Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: A comprehensive standardized system for quantifying renal tumor size, location and depth. J Urol 182 (3):844-853.CrossRef Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: A comprehensive standardized system for quantifying renal tumor size, location and depth. J Urol 182 (3):844-853.CrossRef
18.
go back to reference Boone J, Strauss K. Cody D, McCollough C, et al (2011) Size-specific dose estimates (SSDE) in pediatric and adult body CT examinations. Report of AAPM Task Group 204. Boone J, Strauss K. Cody D, McCollough C, et al (2011) Size-specific dose estimates (SSDE) in pediatric and adult body CT examinations. Report of AAPM Task Group 204.
19.
go back to reference Ahmed M, Solbiati L, Brace CL, et al (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology 273 (1):241-260.CrossRef Ahmed M, Solbiati L, Brace CL, et al (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology 273 (1):241-260.CrossRef
20.
go back to reference Yu J, Zhang G, Liang P, et al (2015) Midterm results of percutaneous microwave ablation under ultrasound guidance versus retroperitoneal laparoscopic radical nephrectomy for small renal cell carcinoma. Abdom Imaging 40 (8):3248-3256.CrossRef Yu J, Zhang G, Liang P, et al (2015) Midterm results of percutaneous microwave ablation under ultrasound guidance versus retroperitoneal laparoscopic radical nephrectomy for small renal cell carcinoma. Abdom Imaging 40 (8):3248-3256.CrossRef
21.
go back to reference Koebe SD, Curci NE, Caoili EM et al (2022) Contrast enhanced CT immediately following microwave ablation of cT1a renal cell carcinoma: Optimizing cancer outcomes. Abdom Radiol (in press) Koebe SD, Curci NE, Caoili EM et al (2022) Contrast enhanced CT immediately following microwave ablation of cT1a renal cell carcinoma: Optimizing cancer outcomes. Abdom Radiol (in press)
22.
go back to reference Wetley KA, Abel EJ, Dreyfuss LE, Huang W, Brace CL, Wells SA (2020) CT and MR imaging surveillance of stage 1 renal cell carcinoma after microwave ablation. Abdom Radiol 45 (9):2810-2824.CrossRef Wetley KA, Abel EJ, Dreyfuss LE, Huang W, Brace CL, Wells SA (2020) CT and MR imaging surveillance of stage 1 renal cell carcinoma after microwave ablation. Abdom Radiol 45 (9):2810-2824.CrossRef
23.
go back to reference Klapperich ME, Abel EJ, Ziemlewicz TJ, et al (2017) Effect of tumor complexity and technique on efficacy and complications after percutaneous microwave ablation of stage T1a renal cell carcinoma: A single-center, retrospective study. Radiology 284 (1): 272-280.CrossRef Klapperich ME, Abel EJ, Ziemlewicz TJ, et al (2017) Effect of tumor complexity and technique on efficacy and complications after percutaneous microwave ablation of stage T1a renal cell carcinoma: A single-center, retrospective study. Radiology 284 (1): 272-280.CrossRef
24.
go back to reference Takaki H, Nakatsuka A, Cornellis et al (2016) False-positive tumor enhancement after cryoablation of renal cell carcinoma: A prospective study. AJR Am J Roentgenol 206 (2):332-339.CrossRef Takaki H, Nakatsuka A, Cornellis et al (2016) False-positive tumor enhancement after cryoablation of renal cell carcinoma: A prospective study. AJR Am J Roentgenol 206 (2):332-339.CrossRef
25.
go back to reference Atwell TD, Schmit GD, Boorjian SA, et al (2013) Percutaneous ablation of renal massess measuring 3.0 cm and smaller: Comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol 200 (2):461-466.CrossRef Atwell TD, Schmit GD, Boorjian SA, et al (2013) Percutaneous ablation of renal massess measuring 3.0 cm and smaller: Comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol 200 (2):461-466.CrossRef
26.
go back to reference Wells SA, Wheeler KM, Mithqal A, Patel MS, Brace CL, Schenkman NS (2016) Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: Short-term efficacy and complications with emphasis on tumor complexity and single-session treatment. Abdom Radiol 41 (6):1203-1211.CrossRef Wells SA, Wheeler KM, Mithqal A, Patel MS, Brace CL, Schenkman NS (2016) Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: Short-term efficacy and complications with emphasis on tumor complexity and single-session treatment. Abdom Radiol 41 (6):1203-1211.CrossRef
27.
go back to reference Yuh BI, Cohan RH (1999) Different phases of renal enhancement: Role in detecting and characterizing renal masses during helical CT. AJR Am J Roentgenol 173 (3):747-755.CrossRef Yuh BI, Cohan RH (1999) Different phases of renal enhancement: Role in detecting and characterizing renal masses during helical CT. AJR Am J Roentgenol 173 (3):747-755.CrossRef
28.
go back to reference Israel GM, Bosniak MA (2008) Pitfalls in renal mass evaluation and how to avoid them. Radiographics 28 (5):1325-1338.CrossRef Israel GM, Bosniak MA (2008) Pitfalls in renal mass evaluation and how to avoid them. Radiographics 28 (5):1325-1338.CrossRef
29.
go back to reference Szczykutowicz TP, Viggiano B, Rose S, Pickhardt PJ, Lubner MG (2021) A metric for quantification of iodine contrast enhancement (Q-ICE) in computed tomography. J Comput Assist Tomogr 45 (6):870-876.CrossRef Szczykutowicz TP, Viggiano B, Rose S, Pickhardt PJ, Lubner MG (2021) A metric for quantification of iodine contrast enhancement (Q-ICE) in computed tomography. J Comput Assist Tomogr 45 (6):870-876.CrossRef
Metadata
Title
Split-bolus CT urography after microwave ablation of renal cell carcinoma improves image quality and reduces radiation exposure
Authors
Alex P. Tannenbaum
Meghan G. Lubner
Ayman Mithqal
Timothy J. Ziemlewicz
Glenn O. Allen
Christopher L. Brace
E. Jason Abel
Lori Mankowski-Gettle
Noah S. Schenkman
Shane A. Wells
Publication date
01-06-2022
Publisher
Springer US
Published in
Abdominal Radiology / Issue 6/2022
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-022-03448-x

Other articles of this Issue 6/2022

Abdominal Radiology 6/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine